相关实验视频
Updated: Jun 28, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.5K
在临床实践中对帕金森病进行深度大脑刺激的基本原理:第1部分
Camila Henriques de Aquino1,2,3, Mariana Moscovich4, Murilo Martinez Marinho3
1University of Calgary, Cumming School of Medicine, Department of Clinical Neurosciences, Calgary, AB, Canada.
Arquivos de neuro-psiquiatria
|April 23, 2024
概括
深度大脑刺激 (DBS) 对帕金森病 (PD) 运动症状提供了经过证明的长期益处. 最佳的患者选择是最大化治疗效果和有效管理并发症的关键.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
背景情况:
- 深度大脑刺激 (DBS) 在过去30年中已成为一种重要的治疗进步.
- 它是帕金森病 (PD) 和其他运动障碍的一种成熟治疗方法.
研究的目的:
- 在临床实践中审查PD的DBS的基本概念.
- 讨论历史方面,患者选择标准和术后管理.
主要方法:
- 对PD的DBS的历史发展和临床应用的回顾.
- 分析患者选择策略和时间.
- 检查DBS对运动和非运动症状的影响.
主要成果:
- DBS在改善PD的心脏运动症状方面表现出长期的有效性.
- 它有效地管理了勒沃多巴诱导的并发症,如运动波动和运动障碍.
- 早期的患者选择对于预防不可逆转的PD并发症至关重要.
结论:
- DBS是一种成熟的帕金森病治疗方法,已被证明可以改善运动症状.
- 精心选择患者和及时干预对于最佳的DBS结果至关重要.
- 本综述为PD管理中的临床DBS实践提供了基础知识.
更多相关视频
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
8.9K
09:46Analysis of Gene Expression Changes in the Rat Hippocampus After Deep Brain Stimulation of the Anterior Thalamic Nucleus
Published on: March 8, 2015
10.9K
相关概念视频
01:24Parkinson's Disease: Treatment
264
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
264
01:15Parkinson's Disease: Overview
537
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
537